Statistics from Altmetric.com
- Inflammatory myofibroblastic tumour
- malignant transformation
- ALK amplification
- TPM3-ALK, gene amplification
- soft tissue tumours
Inflammatory myofibroblastic tumour (IMT) is a distinctive neoplasm that occurs primarily in viscera and soft tissues, and predominantly affects children and young adults. Histologically, IMT is composed of a myofibroblastic spindle cell proliferation accompanied by a mixed inflammatory infiltrate.1 Several studies have shown that up to 30–50% of IMTs contain anaplastic lymphoma kinase (ALK) fusion genes.1–6 The neoplastic cells in IMT are generally uniform and bland. In rare conditions, the tumour may exhibit histological malignant transformation1 3 4 7; however, the molecular biology underlying this evolution is still poorly understood.
Herein, we report a case of a classic IMT that evolved into a high-grade malignant sarcoma with amplification of the TPM3-ALK fusion gene.
A 29-year-old man presented with a history of multiple episodes of abdominal pain for 1 year. An abdominal computed tomography (CT) scan revealed a large left upper quadrant abdominal mass associated with liver lesions. He underwent a subtotal resection of the mesenteric tumour; however, the liver lesions were only biopsied. He received ifosfamide and adriamycin for two complete courses of chemotherapy without response. The patient died of the disease 4 months following the surgery.
Macroscopic inspection revealed a 15.8×15.0×8.2 cm bosselated multinodular mass in the mesentery with transmural involvement of colonic wall. Additionally, multiple omental implants were also present. On sectioning, the mass had a firm pink grey fleshy cut surface …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.